| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 239 |
| 1 | METHOTREXATE SODIUM | 140 |
| 2 | METHOTREXATE | 121 |
| 3 | PREDNISONE | 121 |
| 4 | VEDOLIZUMAB | 120 |
| 5 | TACROLIMUS | 106 |
| 6 | INFLIXIMAB | 104 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 97 |
| 8 | TACROLIMUS OINTMENT 0.1% | 97 |
| 9 | ADALIMUMAB-ADAZ | 86 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARBON DIOXIDE | 1 | 0.0087 |
| 1 | INDIUM IN -111 PENTETREOTIDE | 1 | 0.0078 |
| 2 | ACITRETIN | 26 | 0.0053 |
| 3 | SEVELAMER HYDROCHLORIDE | 3 | 0.0052 |
| 4 | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | 1 | 0.0048 |
| 5 | ETRASIMOD | 8 | 0.0047 |
| 6 | ADALIMUMAB-AFZB | 11 | 0.0041 |
| 7 | PROCAINAMIDE HYDROCHLORIDE | 1 | 0.0040 |
| 8 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 9 | SORBITOL | 2 | 0.0033 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 258 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 194 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 155 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 121 |
| 4 | Integrin Receptor Antagonist [EPC] | 120 |
| 5 | Purine Antimetabolite [EPC] | 68 |
| 6 | Interleukin-12 Antagonist [EPC] | 66 |
| 7 | Interleukin-23 Antagonist [EPC] | 66 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 63 |
| 9 | Proton Pump Inhibitor [EPC] | 49 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 1 | Integrin Receptor Antagonist [EPC] | 120 | 0.0014 |
| 2 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 16 | 0.0007 |
| 4 | Purine Antimetabolite [EPC] | 68 | 0.0007 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 14 | 0.0007 |
| 6 | Interleukin-12 Antagonist [EPC] | 66 | 0.0006 |
| 7 | Interleukin-23 Antagonist [EPC] | 66 | 0.0006 |
| 8 | Alkaloid [EPC] | 16 | 0.0006 |
| 9 | Interferon alfa-2b [EPC] | 1 | 0.0005 |